We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Input Reflected in EMA Revised Draft NIRS Guideline
Industry Input Reflected in EMA Revised Draft NIRS Guideline
March 8, 2012
A European Medicines Agency (EMA) revised draft guideline on the use of near infrared spectroscopy by pharmaceutical companies reflects consensus reached during a May 2011 meeting on the need to clarify NIRS lifecycle and postapproval requirements.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor